Literature DB >> 31843973

Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704.

Marsha Reyngold1, Kathryn A Winter2, William F Regine3, Ross A Abrams4, Howard Safran5, John P Hoffman6, Rex B Mowat7, John P Hayes8, Ivan L Kessel9, Thomas DiPetrillo10, Samir Narayan11, Yuhchyau Chen12, Edgar Ben-Josef13, Guila Delouya14, John H Suh15, Joshua Meyer6, Michael G Haddock16, Marvin Feldman17, Rakesh Gaur18, Kathleen Yost19, Richard A Peterson20, David L Sherr21, Jennifer Moughan2, Christopher H Crane22.   

Abstract

BACKGROUND: Several registry-based analyses suggested a survival advantage for married versus single patients with pancreatic cancer. The mechanisms underlying the association of marital status and survival are likely multiple and complex and, therefore, may be obscured in analyses generated from large population-based databases. The goal of this research was to characterize this potential association of marital status with outcomes in patients with resected pancreatic cancer who underwent combined modality adjuvant therapy on a prospective clinical trial.
MATERIALS AND METHODS: This is an ancillary analysis of 367 patients with known marital status treated on NRG Oncology/RTOG 97-04. Survival analysis was performed using the Kaplan-Meier method and compared using the log-rank test. Multivariate analysis was performed using the Cox proportional hazards regression model.
RESULTS: Of 367 patients, 271 (74%) were married or partnered and 96 (26%) were single. Married or partnered patients were more likely to be male. There was no association between marital status and overall survival (OS) or disease-free survival (DFS) on univariate (hazard ratio [HR], 1.09 and 1.01, respectively) or multivariate analyses (HR, 1.05 and 0.98, respectively). Married or partnered male patients did not have improved survival compared with female or single patients.
CONCLUSION: Ancillary analysis of data from NRG Oncology/RTOG 97-04 demonstrated no association between marital and/or partner status and OS or DFS in patients with resected pancreatic cancer who received adjuvant postoperative chemotherapy followed by concurrent external beam radiation therapy and chemotherapy. Clinical trial identification number. NCT00003216. IMPLICATIONS FOR PRACTICE: Several population-based studies have shown an epidemiological link between marital status and survival in patients with pancreatic cancer. A better understanding of this association could offer an opportunity to improve outcomes through psychosocial interventions designed to mitigate the negative effects of not being married. Based on the results of this analysis, patients who have undergone a resection and are receiving adjuvant therapy on a clinical trial are unlikely to benefit from such interventions. Further efforts to study the association between marital status and survival should be focused on less selected subgroups of patients with pancreatic cancer. © AlphaMed Press 2019.

Keywords:  Marital status; Pancreatic cancer; Radiation therapy; Survival

Year:  2019        PMID: 31843973     DOI: 10.1634/theoncologist.2019-0562

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  12 in total

1.  Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial.

Authors:  William F Regine; Kathryn A Winter; Ross Abrams; Howard Safran; John P Hoffman; Andre Konski; Al B Benson; John S Macdonald; Tyvin A Rich; Christopher G Willett
Journal:  Ann Surg Oncol       Date:  2011-03-10       Impact factor: 5.344

Review 2.  NCI SEER public-use data: applications and limitations in oncology research.

Authors:  James B Yu; Cary P Gross; Lynn D Wilson; Benjamin D Smith
Journal:  Oncology (Williston Park)       Date:  2009-03       Impact factor: 2.990

3.  When the entire population is the sample: strengths and limitations in register-based epidemiology.

Authors:  Lau Caspar Thygesen; Annette Kjær Ersbøll
Journal:  Eur J Epidemiol       Date:  2014-01-10       Impact factor: 8.082

4.  Pancreatic cancer in the USA: persistence of undertreatment and poor outcome.

Authors:  Lindsey Enewold; Linda C Harlan; Thomas Tucker; Shaun McKenzie
Journal:  J Gastrointest Cancer       Date:  2015-03

5.  The impact of marital status on cancer survival.

Authors:  O Kravdal
Journal:  Soc Sci Med       Date:  2001-02       Impact factor: 4.634

6.  Cancer statistics, 2016.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-01-07       Impact factor: 508.702

7.  Participation in cancer clinical trials: race-, sex-, and age-based disparities.

Authors:  Vivek H Murthy; Harlan M Krumholz; Cary P Gross
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

8.  Marital status and survival in patients with cancer.

Authors:  Ayal A Aizer; Ming-Hui Chen; Ellen P McCarthy; Mallika L Mendu; Sophia Koo; Tyler J Wilhite; Powell L Graham; Toni K Choueiri; Karen E Hoffman; Neil E Martin; Jim C Hu; Paul L Nguyen
Journal:  J Clin Oncol       Date:  2013-09-23       Impact factor: 44.544

9.  Marital status and survival in pancreatic cancer patients: a SEER based analysis.

Authors:  Michael Baine; Freshta Sahak; Chi Lin; Subhankar Chakraborty; Elizabeth Lyden; Surinder K Batra
Journal:  PLoS One       Date:  2011-06-15       Impact factor: 3.240

10.  Marital status independently predicts pancreatic cancer survival in patients treated with surgical resection: an analysis of the SEER database.

Authors:  Xiao-Dong Wang; Jian-Jun Qian; Dou-Sheng Bai; Zhen-Nan Li; Guo-Qing Jiang; Jie Yao
Journal:  Oncotarget       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.